The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a remote second opinion program on changes in recommended treatment plans for patients with cancer across the U.S.
 
Allison Lipitz-Snyderman
No Relationships to Disclose
 
Susan Chimonas
No Relationships to Disclose
 
Lauren Klein Levine
No Relationships to Disclose
 
Brendan Raftery
No Relationships to Disclose
 
Cole Manship
No Relationships to Disclose
 
Sergio Giralt
Honoraria - Amgen; Jazz Pharmaceuticals; Sanofi
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Incyte; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi
Research Funding - Actinuum; Amgen; Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Tiffany A. Traina
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; G1 Therapeutics; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Hengrui Pharmaceutical; Merck; Pfizer; Stemline Therapeutics; Tersera
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Pfizer (Inst)
 
Steven Sugarman
No Relationships to Disclose
 
Tiffanny Newman
No Relationships to Disclose
 
Benjamin R. Roman
No Relationships to Disclose